Clincosm LogoSign in Get a demo

digestive system diseases

Showing 1 - 25 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stomach Tumors, Digestive System Tumors, Tumors Trial in Fuzhou (Camrelizumab, SOX, Surgery)

Active, not recruiting
  • Stomach Neoplasms
  • +5 more
  • Fuzhou, Fujian, China
    The Second Affiliated Hospital of Fujian Medical University
Nov 1, 2022

Digestive System Diseases, Inflammatory Bowel Disease, Ulcerative Colitis Type, Crohn Disease Trial in Rennes (additional

Recruiting
  • Digestive System Diseases
  • +2 more
  • additional biopsies
  • Rennes, France
    CHU de RENNES-Service des Maladies de l'Appareil Digestif
Sep 12, 2022

Carcinoma, Gastrointestinal Diseases, Stomach Cancer Trial (Anlotinib HCl capsule, Penpulimab Injection, XELOX)

Not yet recruiting
  • Carcinoma
  • +6 more
  • Anlotinib hydrochloride capsule
  • +2 more
  • (no location specified)
Aug 8, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Colorectal Cancer, RAS and BRAF Wild-type, Colorectal Tumors Trial in Hangzhou (Anlotinib Hydrochloride, Capecitabine,

Completed
  • Colorectal Cancer
  • +12 more
  • Anlotinib Hydrochloride
  • +2 more
  • Hangzhou, Zhejiang, China
  • +1 more
Jul 12, 2022

Liver Diseases, Digestive System Diseases Trial in Miami, Orlando, San Antonio (Ozanimod)

Completed
  • Liver Diseases
  • Digestive System Diseases
  • Miami, Florida
  • +2 more
Jun 13, 2022

Strategies for Hepatitis C Testing and Treatment in Aboriginal

Recruiting
  • Hepatitis C
  • +5 more
  • Fingerstick GeneXpert HCV RNA quantitative assay
  • +2 more
  • Lismore, New South Wales, Australia
  • +3 more
Apr 13, 2022

Palliative Primary Tumor Resection in Minimally Symptomatic

Recruiting
  • Colorectal Neoplasms
  • +12 more
  • Moscow, Russian Federation
    Ryzhikh National Medical Research Center of Coloproctology
Apr 2, 2022

Esophageal Squamous Cell Carcinoma, Esophageal Tumors, Esophageal Diseases Trial (Anlotinib HCl, TQB2450)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • +10 more
  • (no location specified)
Feb 19, 2022

Method of Elderly Condition in Patient Receiving Chemotherapy

Completed
Has Results
  • Lymphoma
  • +5 more
    • Agen, France
    • +17 more
    Jan 27, 2022

    Fatty Liver, Nonalcoholic, NAFLD, Nonalcoholic Fatty Liver Disease Trial in United States (HTD1801, Placebo)

    Completed
    Has Results
    • Fatty Liver, Nonalcoholic
    • +5 more
    • Chandler, Arizona
    • +16 more
    Nov 30, 2021

    Point of Care 3D Ultrasound for Various Applications: A Pilot

    Recruiting
    • Appendicitis
    • +22 more
      • Durham, North Carolina
        Duke University Medical Center
      Sep 21, 2021

      Mechanism of New Biological Probes in Biomedicine

      Recruiting
      • Tumors
      • +10 more
      • No intervention
      • Guangzhou, Guangdong, China
        Nanfang Hospital
      Aug 15, 2021

      Spanish Series of Patients Treated With Radionuclide Lutetium177

      Recruiting
      • Neuroendocrine Tumors
      • +17 more
      • Lutetium [177Lu] oxodotreotide/dotatate
      • Santiago De Compostela, A Coruña, Spain
      • +18 more
      Jul 1, 2021

      Ulcerative Colitis, Digestive System Diseases, Colitis, Ulcerative Trial in Worldwide (KHK4083, Placebo)

      Completed
      Has Results
      • Ulcerative Colitis
      • +9 more
      • Greenville, South Carolina
      • +22 more
      Feb 21, 2020

      Hepatitis, Hepatitis C, Digestive System Diseases Trial (MK-3682B, Ribavirin)

      Terminated
      Has Results
      • Hepatitis
      • +7 more
      • (no location specified)
      Jul 15, 2019

      Celiac Disease, Intestinal Disease, Malabsorption Syndromes Trial in Herston, Sippy Downs, Nedlands (Nexvax2, Placebo)

      Completed
      • Celiac Disease
      • +7 more
      • Nexvax2
      • Placebo
      • Herston, Queensland, Australia
      • +2 more
      Sep 19, 2018

      Low Rectal Cancer Study (MERCURY II)

      Unknown status
      • Adenocarcinoma
      • +15 more
        • Berlin, Germany
        • +16 more
        Sep 17, 2018

        Adenocarcinoma of the Rectum, Adenocarcinoma, Adenocarcinoma, Mucinous Trial in Worldwide (Patients who have surgery at 12 weeks

        Unknown status
        • Adenocarcinoma of the Rectum
        • +16 more
        • Patients who have surgery at 12 weeks after radiotherapy/chemoradiotherapy
        • Sao Paulo, Brazil
        • +22 more
        Sep 14, 2018

        Molecular, Pathologic and MRI Investigation of Prognostic and

        Unknown status
        • Adenocarcinoma
        • +15 more
          • Peterborough, Cambridgeshire, United Kingdom
          • +18 more
          Sep 13, 2018

          Non-Alcoholic Fatty Liver Disease, Fatty Liver, Liver Diseases Trial ("Symbiter Forte", Placebo)

          Completed
          • Non-Alcoholic Fatty Liver Disease
          • +4 more
          • "Symbiter Forte"
          • Placebo
          • (no location specified)
          Aug 4, 2018

          Test for Colorectal Cancer and Other Digestive Tract Cancers

          Terminated
          • Colorectal Neoplasms
          • +3 more
          • Stool Sample Collection Kit
          • Newport Beach, California
          • +21 more
          Apr 4, 2018

          Lymph Node Metastasis in Gastric Cancer(RPLNM)(GIPMCS-1701)

          Unknown status
          • Digestive System Diseases
          • +4 more
            • Guangzhou, Guangdong, China
              Nanfang Hospital, Southern Medical University
            Mar 28, 2018

            Examine Human Gastrointestinal Tract Using Confocal

            Terminated
            • Digestive System Diseases
            • Confocal Imaging
            • New Haven, Connecticut
              Yale New Haven Hospital
            Feb 21, 2018

            Esophageal Tumors, Esophageal Diseases, Digestive System Diseases Trial in Hangzhou (peptide specific CTL)

            Unknown status
            • Esophageal Neoplasms
            • +2 more
            • peptide specific CTL
            • Hangzhou, Zhejiang, China
              Hangzhou Cancer Hospital
            Aug 3, 2017